OR CA · Latest: OR OHA completed a 30-day preliminary review of this transaction on March 16, 2026.
Inform Diagnostics, Inc. and Fulgent Therapeutics, LLC will acquire equity interests of Dermatopathology Experts, LLC and all assets related to the diagnostic and therapeutic services of Bako Pathology Holdings Corp. and its subsidiaries.
| State | Agency | Status | Stage | Source |
|---|---|---|---|---|
| OR | Oregon Health Authority | Approved APPROVED | Preliminary Review PRELIMINARY | Agency record |
| CA | Office of Health Care Affordability (HCAI) | CMIR Waived WAIVED | NOTICE | Agency record |
No changes observed since the initial load (OR · CA ).
| State | Parties as filed |
|---|---|
| OR | InformDx; Bako Pathology |
| CA | Inform Diagnostics, Inc.; Fulgent Therapeutics, LLC |
Grouped by DocketTrail's reviewed seed list, entry inform-diagnostics-fulgent-bako-pathology.
| State | Title as printed | Source key | Key method |
|---|---|---|---|
| OR | 072 InformDx - Bako Pathology | 072 | AGENCY_NUMBER |
| CA | Inform Diagnostics, Inc. / and / Fulgent Therapeutics, LLC | mcn-inform-diagnostics | FIRST_DOCUMENT_SLUG |
| State | Source key | First seen by DocketTrail (UTC) | Last checked (UTC) | Page checked |
|---|---|---|---|---|
| OR | 072 | oregon.gov | ||
| CA | mcn-inform-diagnostics | hcai.ca.gov |
| Source | Last captured (UTC) |
|---|---|
| https://www.oregon.gov/oha/HPA/HP/Pages/072-informdx-bako.aspx | 2026-09-26T07:10:36.031Z |
| https://hcai.ca.gov/affordability/ohca/assess-market-consolidation/material-change-transaction-notices-mcn-and-cost-and-market-impact-review-cmir/ | 2026-10-06T20:33:54.638Z |
| https://www.oregon.gov/oha/HPA/HP/Pages/HCMO-transaction-notices-and-reviews.aspx | 2026-10-06T20:34:08.386Z |